Welcome to LookChem.com Sign In|Join Free
  • or
N,N-bis(methylsulfonyl)-2-iodoaniline is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

636567-58-3

Post Buying Request

636567-58-3 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

636567-58-3 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 636567-58-3 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 6,3,6,5,6 and 7 respectively; the second part has 2 digits, 5 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 636567-58:
(8*6)+(7*3)+(6*6)+(5*5)+(4*6)+(3*7)+(2*5)+(1*8)=193
193 % 10 = 3
So 636567-58-3 is a valid CAS Registry Number.

636567-58-3Relevant academic research and scientific papers

A bioisosteric approach to the discovery of indole carbinol androgen receptor ligands

Lanter, James C.,Fiordeliso, James J.,Allan, George F.,Musto, Amy,Hahn, Do Won,Sui, Zhihua

, p. 5646 - 5649 (2007/10/03)

Two potential bioisosteres of the nonsteroidal antiandrogen bicalutamide, an imidazolidinone and an indole, were synthesized and tested for their androgen receptor binding. Indole was discovered to be a suitable bioisostere for the acyl anilide moiety in the parent compound. Several analogs in the indole series were found to be 10-fold better than bicalutamide in binding to the recombinant androgen receptor binding domain.

NOVEL INDOLE DERIVATIVES AS SELECTIVE ANDROGEN RECEPTOR MODULATOR (SARMS)

-

Page/Page column 40, (2008/06/13)

The present invention is directed to novel indole derivatives, pharmaceutical compositions containing them and their use in the treatment of disorders and conditions modulated by the androgen receptor.

Novel indole derivatives as selective androgen receptor modulators (SARMS)

-

Page/Page column 41-42, (2008/06/13)

The present invention is directed to novel indole derivatives, pharmaceutical compositions containing them and their use in the treatment of disorders and conditions modulated by the androgen receptor.

Novel indole derivatives as selective androgen receptor modulators (SARMS)

-

Page/Page column 41-42, (2010/02/14)

The present invention is directed to novel indole derivatives, pharmaceutical compositions containing them and their use in the treatment of disorders and conditions modulated by the androgen receptor.

Non-imidazole heterocyclic histamine H3 receptor antagonists

Chai, Wenying,Breitenbucher, J. Guy,Kwok, Annette,Li, Xiaobing,Wong, Victoria,Carruthers, Nicholas I.,Lovenberg, Timothy W.,Mazur, Curt,Wilson, Sandy J.,Axe, Frank U.,Jones, Todd K.

, p. 1767 - 1770 (2007/10/03)

Continued exploration of the SAR around the lead imidazopyridine histamine H3 antagonist 1 has led to the discovery of several related series of heterocyclic histamine H3 antagonists. The synthesis and SAR of indolizine, indole and p

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 636567-58-3